Philippines Seizes $21 Million in Counterfeit Goods, Including Kylinbar E-Cigarettes

Mar.13.2025
Philippines Seizes $21 Million in Counterfeit Goods, Including Kylinbar E-Cigarettes
Philippine Customs has sealed a warehouse holding counterfeit goods, including Kylinbar disposable e-cigarettes, valued at approximately 1.2 billion pesos ($21 million). The warehouse operator could face charges.

Key Points:

 

1. A warehouse in the Philippines was raided and found to contain $12 billion pesos ($210 million) worth of suspected illegal e-cigarettes and counterfeit goods.

 

2. The products seized involved the Kylinbar brand of disposable e-cigarettes.

 

3. The warehouse management party may face legal charges if they fail to provide legal import documentation within 15 days.

 


 

2Firsts, reporting from Shenzhen - The Philippine Bureau of Customs (BOC) seized a warehouse in Malabon City, allegedly storing approximately 1.2 billion pesos ($21 million) worth of suspicious illegal e-cigarettes and counterfeit goods.

 

Bienvenido Rubio, the Customs Commissioner, stated at a press conference on Wednesday that the items seized included disposable e-cigarettes, shoes, bags, and cosmetics.

 

Verne Enciso, Director of the Customs Intelligence and Investigation Service (CIIS), said that upon receiving authorization from the Customs Director, they immediately went to a warehouse in Malabon City. 

 

The CIIS team and investigators from the Manila International Container Port (MICP) found disposable e-cigarettes from Kylinbar in the warehouse without labels from the Bureau of Internal Revenue (BIR) and Department of Trade and Industry (DTI).

 

The investigation team temporarily sealed the warehouse and planed to conduct an inventory of the items with customs inspectors, CIIS, the Enforcement and Security Service (ESS), and warehouse representatives. 

 

Warehouse operators were required to provide documents proving the legal acquisition and tax payment of imported goods within 15 days of receiving the authorization letter, or face potential charges under Articles 1113, 117, and 1400 of the Customs Modernization and Tariff Act (CMTA)


They may also face charges under the Intellectual Property Code of the Philippines or Republic Act 8293.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

 Philip Morris Lowers Profit Outlook as Zyn Faces Competition and FDA Delays
Philip Morris Lowers Profit Outlook as Zyn Faces Competition and FDA Delays
According to Reuters, Philip Morris International (PMI) lowered its 2026 adjusted earnings-per-share forecast amid regulatory uncertainty around Zyn nicotine pouches, rising competition and shipment pressure in the U.S. market.
PMI
Jun.02
Special Report | China’s Tobacco Tax Debate Shifts Toward Tax Design as Policy Trade-offs Come Into Focus
Special Report | China’s Tobacco Tax Debate Shifts Toward Tax Design as Policy Trade-offs Come Into Focus
China’s tobacco tax debate is moving from whether to raise prices to how the tax system should be designed. At a Beijing forum on World No Tobacco Day, experts discussed higher specific excise taxes, minimum tax burdens and dynamic adjustments linked to income and inflation. The issue also connects to China’s broader consumption tax reform, health financing and chronic disease costs. Public reports did not mention e-cigarettes, heated tobacco, nicotine pouches or other new nicotine products.
Jun.11
Tasmanian Lower House Passes Tougher Tobacco Bill With Higher Penalties for Sales to Minors
Tasmanian Lower House Passes Tougher Tobacco Bill With Higher Penalties for Sales to Minors
The Tasmanian House of Assembly has passed a new bill aimed at cracking down on the sale of smoking products to children and curbing the illicit tobacco trade. Under the Public Health Amendment (Prohibited Tobacco and Other Products) Bill 2026, businesses caught selling tobacco products to minors would face steeper, tiered fines.
Apr.23 by 2FIRSTS.ai
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13
Reuters: Big Tobacco Emerges as Winner After FDA Regulatory Shift
Reuters: Big Tobacco Emerges as Winner After FDA Regulatory Shift
According to Reuters, major tobacco companies may emerge as key beneficiaries after the U.S. FDA loosened regulations on vaping and nicotine pouch products, a shift that has sparked debate over public health risks.
Industry Insight
May.26
Geneva Court Annuls Ban on Disposable E-Cigarette Sales, Says Power Lies With Federal Authorities
Geneva Court Annuls Ban on Disposable E-Cigarette Sales, Says Power Lies With Federal Authorities
The Geneva Court of Justice on Tuesday upheld appeals filed by four associations and companies active in the tobacco trade and annulled the Geneva legal provision banning the sale of disposable e-cigarettes, commonly known as “puffs.”
Apr.30 by 2FIRSTS.ai